Antibody responses to 43 and 48 kDa antigens of blood-stage Plasmodium berghei in Balb/c mice

被引：3

作者：

Bagai U. ^{[1
]}

Pawar A. ^{[1
]}

Kumar V. ^{[1
]}

机构：

[1] Parasitology Laboratory, Department of Zoology, Panjab University

来源：

Journal of Parasitic Diseases | 2010年 / 34卷 / 2期

关键词：

43; kDa; 48; Antibody; Immunity; Malaria; Plasmodium; Vaccine;

D O I：

10.1007/s12639-010-0012-5

中图分类号：

学科分类号：

摘要：

Progress towards a vaccine against malaria is advancing rapidly with several candidate antigens being tested for their safety and efficacy. In present investigation, two polypeptides (43 and 48 kDa) of Plasmodium berghei (NK-65) were identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Immunogenicity and protective efficacy of both these polypeptides formulated in saponin has been compared in Balb/c mice against challenge infection with P. berghei. Antibody responses were evaluated by indirect fluorescent antibody test and enzyme-linked immunosorbent assay. Merozoite invasion inhibition assay and challenge infections revealed that 48 kDa antigen is better immunogen as compared to 43 kDa and provide better protection against rodent malaria infection. © 2010 Indian Society for Parasitology.

引用

页码：68 / 74

页数：6

共 37 条

[1]

Agrewala J.N., Sumit S., Verma R.K., Mishra G.C., Differential effect of anti B7.1 anti-M150 antibodies in restricting the delivery of costimulatory signals from B-cells and macrophages, J Immunol, 160, pp. 1067-1077, (1998)

[2]

Ahmad N., Masood A.K., Owais M., Fusogenic potential of prokaryotic membrane lipids: Implication in vaccine development, Eur J Biochem, 268, pp. 5667-5675, (2001)

[3]

Akanmori B.D., Waki S., Suzuki M., Immunoglobulin G2a isotope may have a protective role in Plasmodium berghei NK-65 infection in immunized mice, Parasitol Res, 80, pp. 638-641, (1994)

[4]

Banyal H.S., Pandey V.C., Dutta G.P., Subcellular fractionation and localization of marker enzymes of erythrocytic stages of Plasmodium knowlesi, Indian J Parasitol, 3, pp. 9-14, (1979)

[5]

Burns J.M., Dunn P.D., Russo D.M., Protective immunity against P. yoelii malaria induced by immunization with particulate blood-stage antigens, Infect Immun, 65, 8, pp. 3138-3145, (1997)

[6]

Cohen S., Butcher G.A., Properties of protective malarial antibody, Immunology, 19, pp. 369-383, (1970)

[7]

Cox F.E.G., Major animal models in malaria research: Rodents, Malaria: Principles and Practice of Malariology, pp. 1503-1543, (1988)

[8]

Dwivedi V., Vasco A., Vedi S., Dangi A., Arif K., Bhattacharya S.M., Owais M., Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome, Vaccine, 27, pp. 473-482, (2009)

[9]

Freeman R.R., Holder A.A., Characteristics of the protective response of Balb/c mice immunized with a purified P. yoelli schizont antigen, Clin Exp Immunol, 54, pp. 609-616, (1983)

[10]

Galinski M.R., Medina C.C., Ingranallo P., Barnwell J.W., A reticulocyte binding protein complex of P. vivax merozoites, Cell, 69, 7, pp. 1213-1226, (1992)

← 1 2 3 4 →